Ahmad Rumana, Srivastava Arvind K
Division of Biochemistry, Central Drug Research Institute, Chattar Manzil Palace, P.O. Box No. 173, Lucknow 226001, India.
Parasitol Res. 2008 Mar;102(4):805-7. doi: 10.1007/s00436-007-0836-9. Epub 2008 Jan 5.
The rapidly developing resistance to drugs used for prophylaxis and treatment of malaria makes the identification of novel drug targets necessary. Glutathione-S-transferase (GST, E.C. 2.5.1.18), an important enzyme of the glutathione (GSH) cycle, is considered to be an essential detoxification enzyme in malarial parasites. Selective inhibition of this enzyme from malarial parasites by various classes of inhibitors may be viewed as a potential chemotherapeutic strategy to combat malaria. Purified GST from Plasmodium yoelii was inhibited by compounds like protoporphyrin IX, cibacron blue, as well as by the GSH depletor menadione. Cytosolic GST was inhibited to varying degrees by each compound. A characteristic inhibitor constant (Ki) was obtained for each inhibitor. The possible consequences of selective inhibition of parasitic GST to that of the host are discussed in relation to the chemotherapy of malaria.
用于疟疾预防和治疗的药物耐药性迅速发展,因此有必要鉴定新的药物靶点。谷胱甘肽-S-转移酶(GST,E.C. 2.5.1.18)是谷胱甘肽(GSH)循环中的一种重要酶,被认为是疟原虫中一种必不可少的解毒酶。通过各类抑制剂对疟原虫中的这种酶进行选择性抑制,可被视为对抗疟疾的一种潜在化疗策略。来自约氏疟原虫的纯化GST受到原卟啉IX、汽巴克隆蓝等化合物以及GSH消耗剂甲萘醌的抑制。每种化合物对胞质GST均有不同程度的抑制作用。每种抑制剂都获得了一个特征性的抑制常数(Ki)。结合疟疾化疗,讨论了选择性抑制寄生虫GST对宿主GST可能产生的影响。